NEW YORK, Jan. 22 (UPI) -- As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a new study has uncovered neurological and behavioral health benefits amid increased risks for pancreatitis and kidney disease. The study was published this week in the journal Nature Medicine. Advertisement With the drugs' novelty and soaring popularity, it's important for consumers to know about the effects on all organ systems and become aware of the need for